Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

814 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
Garcia-Ruiz PJ, Martinez Castrillo JC, Alonso-Canovas A, Herranz Barcenas A, Vela L, Sanchez Alonso P, Mata M, Olmedilla Gonzalez N, Mahillo Fernandez I. Garcia-Ruiz PJ, et al. Among authors: mata m. J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):840-4. doi: 10.1136/jnnp-2013-306787. Epub 2014 Jan 16. J Neurol Neurosurg Psychiatry. 2014. PMID: 24434037
Non-motor symptom burden is strongly correlated to motor complications in patients with Parkinson's disease.
Santos-García D, de Deus Fonticoba T, Suárez Castro E, Aneiros Díaz A, McAfee D, Catalán MJ, Alonso-Frech F, Villanueva C, Jesús S, Mir P, Aguilar M, Pastor P, García Caldentey J, Esltelrich Peyret E, Planellas LL, Martí MJ, Caballol N, Hernández Vara J, Martí Andrés G, Cabo I, Ávila Rivera MA, López Manzanares L, Redondo N, Martinez-Martin P; COPPADIS Study Group; McAfee D. Santos-García D, et al. Eur J Neurol. 2020 Jul;27(7):1210-1223. doi: 10.1111/ene.14221. Epub 2020 Apr 24. Eur J Neurol. 2020. PMID: 32181979
Behavioral addictions in early-onset Parkinson disease are associated with DRD3 variants.
Castro-Martínez XH, García-Ruiz PJ, Martínez-García C, Martínez-Castrillo JC, Vela L, Mata M, Martínez-Torres I, Feliz-Feliz C, Palau F, Hoenicka J. Castro-Martínez XH, et al. Among authors: mata m. Parkinsonism Relat Disord. 2018 Apr;49:100-103. doi: 10.1016/j.parkreldis.2018.01.010. Epub 2018 Jan 12. Parkinsonism Relat Disord. 2018. PMID: 29361389
Sexual Dysfunction in Early-Onset Parkinson's Disease: A Cross-Sectional, Multicenter Study.
Vela-Desojo L, Urso D, Kurtis-Urra M, García-Ruiz PJ, Pérez-Fernández E, Lopez-Valdes E, Posada-Rodriguez I, Ybot-Gorrin I, Lopez-Manzanares L, Mata M, Borrue C, Ruiz-Huete C, Del Valle M, Martinez-Castrillo JC. Vela-Desojo L, et al. Among authors: mata m. J Parkinsons Dis. 2020;10(4):1621-1629. doi: 10.3233/JPD-202066. J Parkinsons Dis. 2020. PMID: 32925093
Impact of SAfinamide on Depressive Symptoms in Parkinson's Disease Patients (SADness-PD Study): A Multicenter Retrospective Study.
Peña E, Borrué C, Mata M, Martínez-Castrillo JC, Alonso-Canovas A, Chico JL, López-Manzanares L, Llanero M, Herreros-Rodríguez J, Esquivel A, Maycas-Cepeda T, Ruíz-Huete C. Peña E, et al. Among authors: mata m. Brain Sci. 2021 Feb 13;11(2):232. doi: 10.3390/brainsci11020232. Brain Sci. 2021. PMID: 33668408 Free PMC article.
Investigation of Autosomal Genetic Sex Differences in Parkinson's Disease.
Blauwendraat C, Iwaki H, Makarious MB, Bandres-Ciga S, Leonard HL, Grenn FP, Lake J, Krohn L, Tan M, Kim JJ, Gibbs JR, Hernandez DG, Ruskey JA, Pihlstrøm L, Toft M, van Hilten JJ, Marinus J, Schulte C, Brockmann K, Sharma M, Siitonen A, Majamaa K, Eerola-Rautio J, Tienari PJ, Grosset DG, Lesage S, Corvol JC, Brice A, Wood N, Hardy J, Gan-Or Z, Heutink P, Gasser T, Morris HR, Noyce AJ, Nalls MA, Singleton AB; International Parkinson's Disease Genomics Consortium (IPDGC). Blauwendraat C, et al. Ann Neurol. 2021 Jul;90(1):35-42. doi: 10.1002/ana.26090. Epub 2021 May 24. Ann Neurol. 2021. PMID: 33901317 Free PMC article.
[Levodopa in the treatment of Parkinson's disease: myths and realties].
Luquin MR, García-Ruiz PJ, Martí MJ, Rojo A, Vela L, Grandas FJ, Bravo-Utrera M, Burguera JA, Chacón JR, Campos-Arillo VM, Durán-Herrera C, Fernández-García JM, García-Ramos R, Gómez-Esteban JC, Gutierrez J, Juni J, Mata M, Martínez-Castrillo JC, Olivares J, Ribacoba-Montero R, Santos-García D, Sierra M, Valero-Merino C. Luquin MR, et al. Among authors: mata m. Rev Neurol. 2012 Dec 1;55(11):669-88. Rev Neurol. 2012. PMID: 23172094 Free article. Review. Spanish.
Predictors of clinically significant quality of life impairment in Parkinson's disease.
Santos García D, de Deus Fonticoba T, Cores C, Muñoz G, Paz González JM, Martínez Miró C, Suárez E, Jesús S, Aguilar M, Pastor P, Planellas L, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Catalán MJ, Nogueira V, Puente V, Ruíz de Arcos M, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Clavero P, Kulisevsky J, Blázquez Estrada M, Seijo M, Rúiz Martínez J, Valero C, Kurtis M, de Fábregues O, González Ardura J, Ordás C, López Díaz LM, McAfee D, Martinez-Martin P, Mir P; COPPADIS Study Group. Santos García D, et al. NPJ Parkinsons Dis. 2021 Dec 16;7(1):118. doi: 10.1038/s41531-021-00256-w. NPJ Parkinsons Dis. 2021. PMID: 34916528 Free PMC article.
Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies.
Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres-Ciga S, Chang D, Tan M, Kia DA, Noyce AJ, Xue A, Bras J, Young E, von Coelln R, Simón-Sánchez J, Schulte C, Sharma M, Krohn L, Pihlstrøm L, Siitonen A, Iwaki H, Leonard H, Faghri F, Gibbs JR, Hernandez DG, Scholz SW, Botia JA, Martinez M, Corvol JC, Lesage S, Jankovic J, Shulman LM, Sutherland M, Tienari P, Majamaa K, Toft M, Andreassen OA, Bangale T, Brice A, Yang J, Gan-Or Z, Gasser T, Heutink P, Shulman JM, Wood NW, Hinds DA, Hardy JA, Morris HR, Gratten J, Visscher PM, Graham RR, Singleton AB; 23andMe Research Team; System Genomics of Parkinson's Disease Consortium; International Parkinson's Disease Genomics Consortium. Nalls MA, et al. Lancet Neurol. 2019 Dec;18(12):1091-1102. doi: 10.1016/S1474-4422(19)30320-5. Lancet Neurol. 2019. PMID: 31701892 Free PMC article.
Multicentre, randomised, single-blind, parallel group trial to compare the effectiveness of a Holter for Parkinson's symptoms against other clinical monitoring methods: study protocol.
Rodríguez-Molinero A, Hernández-Vara J, Miñarro A, Pérez-López C, Bayes-Rusiñol À, Martínez-Castrillo JC, Pérez-Martínez DA; Monitoring Parkinson’s patients Mobility for therapeutic purposes research group. Rodríguez-Molinero A, et al. BMJ Open. 2021 Jul 19;11(7):e045272. doi: 10.1136/bmjopen-2020-045272. BMJ Open. 2021. PMID: 34281918 Free PMC article.
814 results